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Abstract
Circadian rhythms that function in behaviour and physiology have adaptive significance
for living organisms from bacteria to humans and reflect the presence of a biological clock.
The engine of circadian rhythms is a transcription-translation feedback loop that is fine-
tuned by epigenetic regulation in higher eukaryotes. We elucidated the chromatin struc-
ture of the Bmal1 gene, a critical component of the mammalian clock system, and have
continued to investigate transcriptional regulation including DNA methylation. Various
ailments including metabolic diseases can disrupt circadian rhythms, and many human
diseases are associated with altered DNA methylation. Therefore, regulated circadian
rhythms are important for human health. Here, we summarise the importance of epige-
netic clock gene regulation, including DNA methylation of the Bmal1 gene, from the
viewpoint of relationships to diseases.
Keywords: molecular clock, transcriptional mechanism, cytosine methylation, chromatin,
cancer, metabolic syndrome
1. Introduction
Circadian rhythms function in most living organisms and govern many behavioural and
biochemical processes with 24-h periodicity regardless of changes in the cellular environment.
This is closely associated with the natural rhythm of the sun, which provides light and heat
with 24-h periodicity. The master clock that generates circadian rhythms in mammals is
located in the suprachiasmatic nucleus (SCN) of the hypothalamus and is governed by blue-
light sensing in eyes. Peripheral organs also contain molecular clocks. These biological clocks
control all aspects of physiology such as sleep-wake cycles, body temperature, hormone
secretion, blood pressure and metabolism [1]. Biological clocks oscillate via a mechanism
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based on interlocking transcriptional-translational feedback loops that have both positive and
negative elements. The circadian oscillator orchestrates the rhythmic mRNA expression and
output of hundreds or thousands of clock-controlled genes (CCG) that temporally coordinate
many cellular functions [2]. Circadian transcriptional regulators are apparently involved in the
initial stages of RNA polymerase II recruitment and initiation, as well as the histone modifica-
tions associated with these events to set the stage for gene expression [3]. The methylation of
cytosine on CpG dinucleotides, which is also epigenetic regulation of gene expression, either
directly interferes with the binding of transcriptional regulators or indirectly inactivates a gene
by modulating chromatin to a repressive structure. About 43% of all protein-encoding genes in
mice exhibit circadian rhythms of mRNA abundance somewhere in the body, largely in an
organ-specific manner [4]. The temporal coordination of cellular functions is lost when circa-
dian rhythms are disrupted by age, the environment or genetic mutation, with deleterious
effects on health. For instance, the adrenal steroid hormone glucocorticoid that controls vari-
ous physiological processes, such as metabolism, the immune response, cardiovascular activity
and brain function, is under the control of the circadian clock [5], implying that several
diseases are closely associated with disrupted circadian rhythms.
2. Transcriptional mechanism of the circadian clock
2.1. Basic regulation of circadian transcription
The engine of the mammalian molecular clock consists of a transcription-translation feedback
loop initiated by the transcription factor BMAL1-CLOCK heterodimer. BMAL1 and CLOCK
have paralogs, known as BMAL2 and NPAS2, respectively. Heterodimers such as BMAL1-
CLOCK bind to E-box enhancer sequences and activate the transcription of three Per (Per1,
Per2 and Per3) and two Cry (Cry1 and Cry2) genes. The PER and CRY proteins subsequently
repress the transcription at their own promoters through negative feedback by acting on the
BMAL1-CLOCK heterodimer. The cellular circadian clock mediates the rhythmic output of the
hundreds or thousands of CCG transcripts that are regulated by transcription factors or
coregulators with rhythmic abundance that is a part of the cellular circadian clock [3]. The
prominent transcription factors activated by BMAL1-CLOCK are REV-ERB α and β, which
bind to ROREs, as well as DBP and E4BP4, which bind to D-boxes. E-box motifs contain a core
CANNTG sequence, which is recognised by a basic helix-loop-helix (bHLH) domain that
contains transcription factors. BMAL1-CLOCK binds tandem E boxes spaced 6 or 7 nucleo-
tides (nt) apart with high affinity [6]. The bHLH containing the oncoprotein Myc also binds to
E-boxes and directly activates the expression of multiple repressors of the clock, including Rev-
erbα and Rev-erbβ [7]. In addition, USF1 binds to the E-box motifs ofDbp, Per1 and Per2 [8]. The
RORE motif comprises an AT-rich sequence preceding a core (G/A) GGTCA motif. ROR and
REV-ERB, respectively, activate and repress the transcription of genes by binding to ROREs [9].
They co-ordinately maintain robust circadian expression of core clock proteins, such as BMAL1.
D-boxes are variants of basic leucine-zipper (bZIP) motifs and are 9- or 10-bp palindromes of
two GTAA (C/T) half-site sequences [10]. The D-box motif is bound by the proline- and acidic
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amino acid-rich bZIP (PAR-bZIP) transcription factor family, including DBP, E4BP4, HLF and
TEF [11, 12]. A combination of three binding elements, E-boxes, ROREs and D-boxes, coordi-
nates CCG transcription. Figure 1 shows that most core clock proteins including BMAL1,
CLOCK, PER, CRY, REB-ERB, ROR and E4BP4 bind to many thousands of sites in the genome
in a circadian manner [13].
2.2. Epigenetic mechanism: effect of chromatin structure
Transcriptional regulation initially requires the coordinated control of chromatin and the
genome structure [3]. In general, genetic information is packed into the chromatin structure,
of which the nucleosome is the most basic unit; it determines the large-scale chromatin struc-
ture as a building block and influences transcription. Eukaryotic promoter regions are thought
to have inactive states, assured by the tendency of nucleosomes to inhibit transcription by
protecting protein-DNA interaction. Therefore, chromatin remodelling and loosening of the
nucleosomal barrier including histone tail modifications are key steps in circadian modifica-
tions followed by sequence-specific, transcription factor binding that regulates gene expres-
sions [14]. Distinct chromatin states are determined by unique histone post-translational
modifications. First, histone acetylation levels fluctuate rhythmically at clock gene promoters
and enhancers. Specifically, acetylated histone H3 at Lys27 (H3K27ac), a marker of active
enhancers, and H3 at Lys9 (H3K9ac) are rhythmic and positively correlate with clock gene
expression. For example, rhythmic BMAL1-CLOCK binding and H3K9ac are required as well
as rhythmic histone H3 abundance at the start site for Dbp transcription [15]. Complexes of
clock proteins such as PER contain various interactive partners with known catalytic activity
towards chromatin [16, 17]. The acetylation of histone H3 (at Lys9 and Lys14) at Per1, Per2 and
Cry1 and of H4 at Per1 during the transcriptional activation phase has been identified [18, 19].
Rhythmic histone acetylation at clock loci is largely mediated by p300 and CBP histone
Figure 1. Hierarchical regulation mechanism of circadian transcription. E, RORE and D indicate transcription factor recogni-
tion sites: E-box, RORE and D-box, respectively.
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acetyltransferases (HAT) [15, 19], and CLOCK itself might also have intrinsic HAT activity
[20]. Levels of histone acetylation are also regulated by histone deacetylases (HDAC) as well as
by HAT. Several HDAC are important in the control of circadian histone acetylation. For
example, REV-ERBα represses transcription in part by recruiting the co-repressor complexes
NCoR and/or SMRT to ROREs [21]. One major mechanism of transcriptional repression medi-
ated by CRY and PER is the direct recruitment of the Sin3 complex, which contains HDAC1
and HDAC2 [17]. Another co-repressor complex containing HDAC1 and HDAC2 subunits,
NuRD, binds PER-CRY and deacetylates nearby histones, thereby represses clock genes [22].
Sirtuins are another class of HDAC involved in the core clock mechanism that associate with
the BMAL-CLOCK heterodimer, and levels of their common cofactor, nicotinamide adenine
dinucleotide, are under tight circadian control in many physiological systems [23, 24]. In
addition to being acetylated, lysine side chains can be methylated by methyltransferases, and
their deacetylation often precedes and facilitates an acetylation-methylation switch. Histone H3
at Lys9 methylation (H3K9me) promotes heterochromatin formation and transcriptional repres-
sion. Rhythmic H3K9me near circadian E boxes is mediated by SUV39 methyltransferase and is
antiphase to H3K9ac rhythms in the mouse liver [15]. The di- and trimethylation of H3 at Lys27
also proceed at Per1 and Per2 during the repressive phase [25]. The circadian clock regulates
global transcriptional integrity and chromatin status by regulating RNA polymerase II, because
circadian transcription is clustered in phase and accompanied by circadian control of RNA
polymerase II recruitment and initiation [26]. The above individual mechanism is governed by
the three-dimensional (3D) architecture of chromatin and its critical contributions to long-
distance cis-acting mechanisms of gene regulation [27]. Regulatory elements such as enhancers,
silencers and insulators built up functional 3D architectures in the nucleus and manage the
transcription factory with specific properties [28]. Several looping factors, such as components
of the Mediator complex, interact with clock transcription factors [29]. Deletion of one of the
factors important for looping, Smc3, causes major disruptions to the clock [30]. Recently, the
detailed 3D multi-loop aggregate/rosette chromatin architecture and functional dynamics have
been revealed [31, 32], and this may explain how physiological functions are regulated with a
tissue-specific rhythm in spite of the same core clock system. These results suggest that epige-
netic regulation caused by the chromatin structure is important for circadian transcription, and
further researches from the viewpoint of 3D chromatin structure are required to elucidate the
physiological function with circadian rhythm in the tissue.
2.3. DNA methylation
The most common epigenetic modification is DNA methylation, which is a covalent chemical
alteration that plays a crucial role in numerous biological processes. It occurs in mammals
predominantly on cytosine residues in cytosine-guanine (CpG) dinucleotides, and tissue-
specific genomic DNA methylation patterns play a fundamental role in establishing cell iden-
tity during differentiation. Generally, although about 70% of all CpG sequences in mouse and
human genomes are methylated, CpG islands in promoter sequences are methylated at a
relatively lower level [33]. Overall, DNA methylation exhibits no major rhythmic changes and
the cellular function of DNA methylation depends on which gene is methylated. One of the
most important issues regarding DNA methylation is how the machinery is directed towards
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and maintains specific genomic sequences. One mechanism might be the PML-RAT fusion
protein in leukaemia, which induces DNA hypermethylation and gene silencing at specific
target promoters [34]. Another is siRNA-mediated, RNA-directed DNA methylation, which is
a stepwise process initiated by dsRNA that recruits DNMT to catalyse the de novo DNA
methylation of specific regions [35]. Therefore, the susceptibility of individual CpG islands to
de novo methylation might intrinsically differ, but the mechanism remains obscure. In any
event, CpG methylation is strictly regulated and stable, and changes in methylation profiles
are associated with diseases, indicating close relationships among DNA methylation sites, the
mechanism of methylation and biological functions.
3. Transcriptional regulation of the Bmal1 gene
Bmal1was originally characterised due to its high expression levels in brain andmuscle cells [36].
The activity of Bmal1/ mice immediately becomes arrhythmic in constant darkness; therefore,
BMAL1 is apparently an essential and non-redundant component of the mammalian clock [37].
Among the core clock genes, BmalL1 expression oscillates in the SCN and in peripheral clock
cells, in close association with circadian rhythms [38]. We evaluated the chromatin structure of
the Bmal1 gene and discovered a unique structure within the Bmal1 promoter. The Bmal1 pro-
moter region comprises mainly a general nucleosome structure upstream of a 50 SacI site, an
open chromatin structure around RORE and a nuclear matrix-like structure at a 30-flanking
region (Figure 2). Oscillatory transcription of the Bmal1 gene requires the chromatin structure to
undergo rhythmic alterations in vivo at the region around the ROREs and at the 30-flanking
region in response to SAF-A binding, indicating cooperative alteration of the chromatin structure
between the 30-flanking region and the ROREs [39]. The methylation of DNA on CpG islands
results in transcriptional repression either by interfering with transcription factor binding or by
including a repressive chromatin structure [40]. The methylation of CpG adjacent to the core Sp1
motif decreases Sp1/Sp3 binding [41], which might be associated with the repression of Bmal1
transcription by DNA methylation, because many putative Sp1-binding motifs are located
around the Bmal1 promoter. The level of DNA methylation within a 1 kb region surrounding
the transcription start site closely correlates with gene repression, and the promoter of clock
genes including Bmal1 is usually unmethylated [39]. However, the hypermethylation of CpG
islands in the promoter of Bmal1 transcriptionally silences its expression in haematological
Figure 2. Chromatin structure of Bmal1 promoter. Oval, unfilled boxes and arrow near BamHI indicate nucleosome,
RORE and transcription start site, respectively. RORE: recognition motifs for retinoic acid receptor-related orphan recep-
tor (ROR) and reverse Erb (REV-ERB) orphan nuclear receptors.
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malignancies [42, 43]. Relationships between the DNA methylation of clock genes and diseases
have been identified. The ROREs, which are critical elements for Bmal1 oscillatory transcription
[44], are embedded in a unique GC-rich open chromatin structure. We also found that DNA
demethylation of the Bmal1 promoter enhances Bmal1, and then Per2 and Cry1 transcription that
function in the circadian oscillation of Bmal1 transcription recover, suggesting that the circadian
rhythm is restored [42, 43]. Furthermore, DNAmethylation might contribute to the developmen-
tal expression of clock genes [45]. These lines of evidence suggest that the DNA methylation of
clock genes, in particular, Bmal1, plays a key role in the disruption of circadian rhythms that are
closely associated with various diseases.
We recently found that recovery from DNA methylation by 5-aza-20-deoxycytidine (aza-dC)
differs between the Bmal1 and Rpib9 genes, suggesting that the release of methylation depends
on the locus/gene or sequence and that methylation status is specific to the DNA site [46].
Taken together, these findings imply that methylation is specific to gene function and that an
early response to the aza-dC demethylation of sites in Bmal1 might be functionally important
for adaptation to environmental change.
4. Disease
Appropriate circadian gene expression is necessary for the normal cell development. That is,
distorted clock gene expression leads to various diseases. This chapter focuses on cancers and
some other diseases.
4.1. Cancer
Close relationships between clock gene expression and the initiation and progression of cancer
are obvious from the findings of many studies. Clock gene expression is altered in many types of
malignancies including breast, lung, haematopoietic, pancreatic and skin cancers. Clock genes
are apt to be downregulated inmany cancer types, as shown inTable 1. These phenomena imply
that clock genes have some anti-tumour effects. The physiological disruption of circadian
Gene Expression Mechanism Cancer type DNA methylation References
Per1 Downregulated Apoptosis Colon, lung, breast — [38]
Per2 Downregulated Apoptosis Lung, lymphocyte — [36, 37]
Downregulated MYC-downregulation Lung, breast — [34, 36, 37]
Downregulated p53-upregulation Lung, breast — [36, 37]
Cry2 Downregulated Unknown Breast Hypermethylation [39, 40]
Bmal1 Downregulated p53 pathway Pancreas — [35]
Downregulated p300, CAT activation Leukaemia Hypermethylation [29, 33, 34]
Table 1. Clock genes and their possible functions for cancer suppression.
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rhythms and the genetic loss of Per2 or Bmal1 promote tumorigenesis in lung cancer [47], and
such disruptions are associated with upregulated c-Myc levels. The expression of Bmal1 is
suppressed in pancreatic cancer, and this gene activates the p53 tumour suppressor pathway,
playing an important role in cancer suppression [48]. Fu et al. found that PER2 is an important
factor for tumour suppression and the DNA damage response [49]. The overexpression of Per1
or Per2 can lead to the apoptosis of cancer cells [50, 51]. Mao et al. reported that Cry2 expression
is decreased in breast cancer, resulting in an altered methylation pattern in CpG islands [52]. The
findings of another study support this observation, and CRY2 suppression is closely associated
with risks for breast cancer [53]. From a mechanistic viewpoint, one of the main factors in such
disrupted circadian gene expression might be MYC. According to a report by Altman et al., this
gene directly activates REV-ERB, which suppresses Bmal1, and their constitutive expression
suspends clock mechanisms [7]. These findings suggest that the appropriate expression of clock
genes is necessary to maintain normal tissues. On the other hand, leukaemia stem cells in acute
myeloid leukaemia (AML) have intact circadian expression. Furthermore, knockdown studies
have shown that Bmal1 and Clock are required for AML cell growth and that disrupted circadian
rhythm machinery is an anti-leukaemic factor that leads to leukaemia stem cell differentiation
[54]. In addition, upregulated Clock plays critical roles in the proliferation of colorectal carcinoma
cells and the inhibition of apoptosis [55].
The roles of clock genes seem to differ among stages or tissues in patients with cancer. In
addition to classical genetic mutations, the epigenetic landscapes of cancer cells are rather
contorted. From an epigenetic perspective, clock genes functionally associate with histone mod-
ifying genes that are responsible for cancer progression and maintenance. Mixed lineage leukae-
mia (MLL) genes were originally discovered through detailed analyses of leukaemogenic
rearrangement but they are now thought to be responsible for histone H3K4 methyltransferase
activity and promoters of target gene transcription. Mutations of MLL genes literally trigger
mixed lineage leukaemia and are necessary to maintain malignancy through aberrant epigenetic
gene regulation [56]. The relationship between MLL genes and circadian rhythm maintenance
through histone modification has been studied in detail. According to Katada et al., MLL1 has
CLOCK-associated histone modifying activity, and it is necessary to generate circadian rhythms
in fibroblasts [57]. Kim et al. found that MLL3 and 4 are factors that regulate circadian rhythmic
homeostasis in the liver [58]. In addition, MLL3 contributes to circadian rhythm generation in
mouse embryonic fibroblasts (MEFs) [59]. The histone modifying enzyme EZH2 is another
histone-lysine N methyl transferase that is responsible for histone H3K27 methyl transfer. This
modification results in transcription repression. Ezh2 also promotes tumorigenesis by altering the
expression of numerous tumour suppressor genes [60]. EZH2 interacts with CLOCK-BMAL1
complexes and is necessary for circadian rhythm maintenance [25]. Although CLOCK per se is
not considered to be an oncogene, it might affect cancer cell proliferation if it is atypically
expressed [55].
Considering the altered methylation patterns of the promoter regions of clock genes, the
features of epigenetic abnormalities of cancer cells comprise highly methylated CpG islands
of specific genes accompanied by low methylation status of other genes [61]. Some studies
have indicated that this phenomenon is true for clock genes. The Cry2 promoter tends to be
highly methylated in patients with breast cancer, resulting in lower Cry2 expression compared
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with controls [43]. Taniguchi et al. reported that CpG islands of the Bmal1 promoter are
hypermethylated in diffuse large B-cell lymphoma and in acute lymphocytic and myeloid
leukaemia [42]. We also reported this phenomenon and that the methylation pattern of the
Per2 promoter region does not change in RPMI8402 cells [46]. The aberrant methylation
pattern of the Bmal1 promoter was restored, and the intrinsic rhythm was revived after 1 day
of aza-dC treatment. These findings indicate that active mechanisms in leukaemia cells main-
tain the promoters of hypermethylated Bmal1 gene status.
As noted above, many studies have emphasised close relationships between epigenetic modifi-
cation and circadian clock genes in cancer proliferation and progression. However, the precise
mechanisms seem highly complex and remain obscure. Further investigation is required to
elucidate these mechanisms.
4.2. Other diseases
Circadian rhythms are also associated with diseases other than cancer through effects on the
cardiovascular, renal, immune, endocrine, neuropsychiatric and metabolic systems [5, 62–67].
Many physiological processes cannot be harmonised when the intrinsic rhythm is aberrant and
such dyssynchrony leads to many diseases.
Here, we consider neuropsychiatric disorders. Disrupted sleep-wake cycles, depression,
Alzheimer’s disease and mood disorders among neuropsychiatric disorders are notably linked
to altered circadian rhythms. However, circadian epigenomics have received less consideration
in studies of neuropsychiatric disorders compared with cancers.
Alzheimer’s disease is an age-dependent neurodegenerative disorder that is associated with
severe cognitive impairment, and its incidence is increasing, particularly in developed countries
due to extended life spans. The typical clinical symptoms are disordered circadian rhythms and
abnormal sleep patterns. Amyloid beta is a key molecule in this neurodegeneration [68], and it
reportedly degrades BMAL1 protein [69]. The lack of this powerful rhythm generator disrupts
circadian rhythms in many patients. Furthermore, the methylation rhythm of the Bmal1 pro-
moter changes in the neocortex of patients with this disease. These phenomena imply that the
aberrant methylation of the Bmal1 promoter and rapid BMAL1 degradation together affect
behavioural changes or cognitive impairments. Furthermore, a methylome study of the neocor-
tex of brains at autopsy revealed attenuated methylation rhythms in samples from patients with
Alzheimer disease compared with controls [70]. The neocortex is very rare in terms of tissues
with circadian methylation rhythms.
According to many studies, contorted clock gene expression patterns and mood disorders are
closely associated in experimental animal models. Genetic experiments have found that
CLOCK is a key factor in maniac states because Clock mutant mice (ClockΔ19) develop clear
features [71–73] of mania, circadian rhythm disruption, hyperactivity and decreased sleep. The
physiological features of these mutant mice include altered gene expression patterns and
excited neurons due to upregulated dopamine content in the ventral tegmental area (VTA)
[74]. Notably, knockdown of CLOCK in the VTA using RNA interference results in concomi-
tant mania-like (hyperactivity and decreased anxiety) and depression-like behaviours in mice.
Since patients with mania often experience depressive episodes, this knockdown mouse is a
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more appropriate model of mania in humans. However, precisely how these CLOCK disrup-
tions affect the upregulated dopamine content in the VTA remains obscure. The expression of
monoamine oxidase A (MAOA), which inactivates monoamine neurotransmitters including
dopamine, serotonin and norepinephrine, is regulated by circadian clock genes including Bmal1,
Npas2 and Per2 [75]. However, in this mechanism, CLOCK, unlike NPAS2, does not work as a
transcriptional activator. Therefore, the absence of CLOCK directly results in downregulated
MAOA activity, and consequent dopamine upregulation cannot be concluded. Some other
CLOCK functions including histone modification activity or an indirect action of CLOCK might
be involved in dopamine upregulation, and investigations into this are underway.
Patients with depression frequently have insomnia and abnormal circadian rhythms that could
reasonably relate to altered clock gene expression. Circadian clock gene expression has been
compared between post-mortem brain samples from patients with major depressive disorder
(MDD) and age-matched controls [76]. The findings showed abnormal clock gene phasing and
decreased Bmal1 and Per2 oscillation in most brain regions of the patients. These findings
provided direct evidence that clock gene expression is altered in the central nervous system of
patients with MDD. On the other hand, depression states and anti-depressant effects are often
tested in experimental animal models such as laboratory mice that are suspended by the tail or
forced to swim to mimic short duration stress or exposed to social defeat to mimic chronic stress
[77]. The volume of the hippocampus is reduced in both patients and in a model that develops
depressive pathophysiology after exposure to chronic stress, and this volume is restored by
administering anti-depressant medicine. Brain-derived neurotropic factor (BDNF) plays a very
important role in the hippocampus as an anti-depressant and for adaptation to stress. Anti-
depressants enhance BDNF expression in the mouse brain [78]; BDNF infused into the hippo-
campus has anti-depressant effects in behavioural mouse models of depression [78, 79] and the
action of the anti-depressant desipramine is attenuated mice with a BDNF deletion in the
forebrain [78, 80]. Expression of Bdnf gene is rhythmic in rat brain regions including hippocam-
pus. However, its downregulation in an animal model of depression was due to the methylation
status of the promoter region of the Bdnf gene [81]. Tsankova et al. found that the expression of
two BDNF variants, Bdnf III and IV, is downregulated and that the promoter regions of corresp-
onding variants are hypermethylated in laboratory mice exposed to defeat stress [82]. Further-
more, chronic imipramine administration increased histone acetylation on the corresponding
promoters, and this downregulation was reversed. The findings of the above studies indicate
that Bdnf gene expression is rhythmically maintained under normal conditions but is epigeneti-
cally regulated under stress. However, precisely how Bdnf expression is rhythmically maintained
remains unclear and awaits further investigation.
5. Assays of Bmal1 transcription modulators
The circadian clock controls the daily oscillations of gene expression and physiological function
at the cellular level, indicating that the control of circadian rhythms at the cellular level is
important for human health. After we elucidated the transcriptional mechanism of the non-
redundant essential unique clock gene, Bmal1, we developed a circadian functional assay system
that consists of luminescent reporter cells and the application of Bmal1 findings. We found that
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the minimal essential region of the Bmal1 promoter for circadian transcription is embedded in an
open chromatin structure, suggesting that this region can remain functional even when inserted
into a reporter plasmid [39]. We then established stable reporter cell lines with which to analyse
circadian clock function [83] and the effects of DNAmethylation on circadian clock function [43].
Figure 3 shows the application of these systems to further dissection of the molecular mecha-
nisms underlying the mammalian circadian clock [46, 84, 85].
One of the most important findings was that altering the DNA configuration of the Bmal1
promoter causes the epigenetic regulation of Bmal1 circadian transcription [86]. Topoisomerase
I (TOP1) is located at an intermediate region between two ROREs that are critical cis-elements
of circadian transcription, which is required for transcriptional suppression in cooperation
with the distal RORE. The DNA fragment between the ROREs, where the TOP1-binding site
is located, behaved like a right-handed superhelical twist, and the modulation of TOP1 activity
by the TOP1 inhibitor, camptothecin and Top1 siRNA altered the footprint, indicating the
modulation of the chromatin structure. These findings indicated that TOP1 modulates the
chromatin structure of the Bmal1 promoter, regulates the Bmal1 transcription and influences
the circadian period.
Figure 3. Monitoring cellular circadian clock system using stable reporter cell line. (A) Monitoring method. Promoter
region (202 to +27) of Bmal1 was inserted into pGL3-dluc and used to create cell lines with stable, real-time reporter gene
to evaluate cellular circadian clock system. (B) Circadian oscillation monitored using host NIH3T3 cells. (C) Circadian
oscillation monitored using host CPT-K cells with hypermethylated Bmal1 promoter region. Cells with stable gene
expression derived from CPT-K cells were incubated with 2.5 μM aza-dC for 2 days, stimulated with 50% FBS for 2 h
and then bioluminescence was measured. Detrended fit curves are representative of at least three independent experi-
ments (control, grey; aza-dC, black). Dots, raw values; lines, fit curve data.
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Another important finding was the epigenetic inactivation or DNA methylation of the Bmal1
promoter. The methylation status of the Bmal1 promoter is critical for the circadian system.
Because the Bmal1 gene is inactivated by the DNA hypermethylation of its promoter, the
circadian oscillation of Bmal1 transcription was absent in the haematological malignant cells.
The demethylating agent aza-dC restored circadian oscillation, whereas continuous Bmal1
expression did not. Because BMAL1 protein has distinct tissue-specific regulation and func-
tions [87], tissue-specific regulation of BMAL1 expression might be required, and this can be
introduced endogenously by aza-dC to establish the negative feedback loop system and
restore circadian oscillation. Because the Bmal1 promoter is basically hypomethylated, the
methyltransferases DNMT3a and DNMT3b might be mainly responsible for introducing cyto-
sine methylation de novo at unmethylated CpG sites in the promoter [40]. The methylation of
DNA contributes to the expression of clock genes [45] in addition to Bmal1, a key player in the
disruption of circadian rhythms.
6. Conclusion
Circadian rhythms control all aspects of physiology. When they are disrupted by changes in clock
gene expression, various critical intracellular physiological processes become dysregulated, and
this can lead to diseases that are induced partly by epigenetic effects including DNA methyation.
The pathologies that are closely associated with disrupted circadian rhythms include cancer [88],
dementia [89], Parkinson’s disease [90] and obesity [91]. Among the clock genes, Bmal1 is unique
because the loss of BMAL1 protein in mice results in immediate and complete loss of circadian
rhythmicity [33], indicating the importance of a specific amount of BMAL1 expression for circa-
dian rhythms. In addition, DNAmethylation of the Bmal1 promoter disrupts the circadian system
even when the Per and Cry gene promoters are unmethylated, indicating that the Bmal1 gene is
functionally important [43]. Epigenetic regulation, especially DNA methylation status, is specific
to DNA sites and gene functions. Therefore, the finding that the epigenetic transcriptional regula-
tion of Bmal1 is functionally important for adaptation to environmental changes provides novel
insights into clock gene functions that should affect the clinical diagnosis and treatment of
diseases. Therefore, modulators of Bmal1 transcription are needed for the human health.
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